FDA Brief

Company record

Cangene BioPharma, LLC dba Emergent BioSolutions

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Cangene BioPharma, LLC dba Emergent BioSolutions.

Warning letters

  1. Cangene BioPharma, LLC dba Emergent BioSolutions

    FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.

    High risk